Skip to Main Content

Paper Details

Pharmacologic and genetic approaches define human pancreatic β cell mitogenic targets of DYRK1A inhibitors.
JCI Insight
31
2020
Author NameAffiliation
Roberto SanchezDrug Discovery Institute
Roberto SanchezDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
  • 1 - 2

Datasets

Release 1.2